Board Member
Faeth Therapeutics, Inc. (FTH)Chief Accounting Officer
4D Molecular Therapeutics, Inc. (FDMT)Chief Accounting Officer
Viridian Therapeutics, Inc.\DE (VRDN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2026-06-10–present
2026-03-25–present
2021-07-26–present
2021-07-26–present
2026-06-10–2026-06-12
Start not stated–2023-09-12
Start not stated–2025-11-14
Start not stated–2025-11-14
Recorded roles and earnings-call appearances connecting this person to public companies.
CFO, Chief Accounting Officer
2021-07-26–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Foghorn Therapeutics Inc. (FHTX) | Chief Financial Officer | $336,458 | $1,888,603 |
| 2022 | Viridian Therapeutics, Inc.\DE (VRDN) | Chief Financial and Business Officer | $561,800 | $2,023,780 |
| 2021 | Viridian Therapeutics, Inc.\DE (VRDN) | Chief Financial and Business Officer | $230,871 | $7,708,958 |
Earnings-call appearances and filed executive appointments or departures, newest first.
